S
Stanton B. Elias
Researcher at Henry Ford Health System
Publications - 40
Citations - 2115
Stanton B. Elias is an academic researcher from Henry Ford Health System. The author has contributed to research in topics: Myasthenia gravis & Experimental autoimmune encephalomyelitis. The author has an hindex of 19, co-authored 40 publications receiving 1947 citations. Previous affiliations of Stanton B. Elias include University of Texas at Austin & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky,Ponnada A. Narayana,Paul O'Connor,P. K. Coyle,Corey C. Ford,Kenneth P. Johnson,Kenneth P. Johnson,Aaron Miller,Aaron Miller,Lillian Pardo,Shaul Kadosh,David Ladkani,Lorne F. Kastrukoff,Pierre Duquette,Mark S. Freedman,Marc Debouverie,Catherine Lubetski,Gilles Edan,E Roullet,Christian Confavreux,Alan J. Thompson,L D Blumhardt,L D Blumhardt,Stanley Hawkins,Thomas F. Scott,Daniel Wynn,Joanna Cooper,Stephen Thurston,Stanton B. Elias,Clyde E. Markowitz,David Mattson,John H. Noseworthy,Elizabeth A. Shuster,Jonathan L. Carter,Fred D. Lublin,WH Stuart,Michael D. Kaufman,Gary Birnbaum,Kottil Rammohan,Ruth H. Whitham,Cornelia Mihai,Steven J. Greenberg,Craig M. Smith,Mark A. Agius,Stan Van Den Noort,Lawrence W. Myers,James G. Nelson,Douglas S. Goodin,Barry G. W. Arnason,Khurram Bashir,Sharon G. Lynch,Patricia K. Coyle,Stephen Kamin,William A. Sheremata,Galen Mitchell,Andrew D. Goodman,Norman J Kachuck,Peter B. Dunne,J. William Lindsey,Elliot M. Frohman,James D. Bowen,Benjamin Rix Brooks,John W. Rose,Harold L. Moses,Douglas Jeffrey,Anne H. Cross,Robert P. Lisak,Timothy Vollmer,Jack P. Antel,Gary Cutter,Luanne M. Metz,Henry F. McFarland,Steven Reingold,Fred D. Lublin,Irina Vainrub,Lucie Lambert,Fengwei Zhong,Jeff Rasmituth,Saria Momin,Rivka Kreitman,Galia Shifroni,Irit Pinchasi,Yafit Stark +82 more
TL;DR: To determine whether glatiramer acetate slows accumulation of disability in primary progressive multiple sclerosis, a new drug is developed that acts as a ‘spatially aggregating agent’ to reduce the risk of disease progression.
Journal ArticleDOI
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice.
Jing Zhang,Yi Li,Jieli Chen,Yisheng Cui,Mei Lu,Stanton B. Elias,James B. Mitchell,Lora Hammill,Padmavathy Vanguri,Michael Chopp,Michael Chopp +10 more
TL;DR: Data indicate that hBMSC treatment improved functional recovery after EAE in mice, possibly, via reducing inflammatory infiltrates and demyelination areas, stimulating oligodendrogenesis, and by elevating BDNF expression.
Journal ArticleDOI
Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study.
TL;DR: It is concluded that the correction rate of hyponatremia plays a significant role in the pathogenesis of pontine lesions in individuals with profound hypon atremia who undergo large increases in sodium concentration as a result of severe initial hyponAtremia.
Journal ArticleDOI
Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice
Jing Zhang,Yi Li,Mei Lu,Yisheng Cui,Jieli Chen,Lori Noffsinger,Stanton B. Elias,Michael Chopp,Michael Chopp +8 more
TL;DR: It is indicated that hBMSCs improve functional recovery and may provide a potential therapy aimed at axonal protection in EAE mice, in which NGF may play a vital role.
Journal ArticleDOI
Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins
TL;DR: It is suggested that circulating globulins in myasthenia gravis may contribute to the functional defects of neuromuscular transmission by accelerating the rate of internationalization and degradation of surface membrane acetylcholine receptors.